Cas:94109-79-2 2,4-bis(2-methylbutan-2-yl)-6-(1-oxidobenzotriazol-1-ium-2-yl)phenol manufacturer & supplier

Chemical Name:2,4-bis(2-methylbutan-2-yl)-6-(1-oxidobenzotriazol-1-ium-2-yl)phenol

CAS.NO:94109-79-2

Synonyms:EINECS 302-519-0;2,4-bis(1,1-dimethylpropyl)-6-(1-oxido-2H-benzotriazol-2-yl)phenol;2-(2H-Benzotriazol-2-yl)-4,6-bis(tert-pentyl)phenol N-oxide;2-(2’H-Benzotriazol-2′-yl)-4,6-di-tert-pentylphenol 1′-oxide;2-(2’H-benzotriazol-2′-yl)-4,6-bis(1′,1′-dimethylpropyl)phenol 1′-oxide;2-(2-hydroxy-3,5-di-t-amylphenyl)benzotriazole-N-oxide

Molecular Formula:C₂₂H₂₉N₃O₂

Molecular Weight:367.48500

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:63.51000

Exact Mass:367.22600

LogP:5.53480

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like EINECS 302-519-0 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-hydroxy-3,5-di-t-amylphenyl)benzotriazole-N-oxide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-bis(1,1-dimethylpropyl)-6-(1-oxido-2H-benzotriazol-2-yl)phenol Use and application,2-(2-hydroxy-3,5-di-t-amylphenyl)benzotriazole-N-oxide technical grade,usp/ep/jp grade.

Related News: If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such. 2,4-bis(2-methylbutan-2-yl)-6-(1-oxidobenzotriazol-1-ium-2-yl)phenol manufacturer Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 2,4-bis(2-methylbutan-2-yl)-6-(1-oxidobenzotriazol-1-ium-2-yl)phenol supplier If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such. 2,4-bis(2-methylbutan-2-yl)-6-(1-oxidobenzotriazol-1-ium-2-yl)phenol vendor Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� 2,4-bis(2-methylbutan-2-yl)-6-(1-oxidobenzotriazol-1-ium-2-yl)phenol factory Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.